Rajesh Chopra Selected Research

Rajesh Chopra Research Topics

Disease

15	Neoplasms (Cancer) 01/2021 - 08/2002
9	Multiple Myeloma 01/2019 - 06/2005
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 12/2004
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2015 - 10/2010
3	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2004 - 02/2002
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2013
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2017 - 12/2004
2	Disease Progression 12/2016 - 10/2015
2	Glioblastoma (Glioblastoma Multiforme) 04/2016 - 10/2013
2	Thalassemia 08/2015 - 04/2014
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2015 - 02/2013
2	Anemia 04/2014 - 04/2014
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2011 - 02/2006
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2016
1	Fibrosis (Cirrhosis) 12/2016
1	Brain Neoplasms (Brain Tumor) 04/2016
1	Pulmonary Echinococcosis 03/2016
1	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 08/2015
1	Lymphoma (Lymphomas) 04/2015
1	Inflammation (Inflammations) 01/2015
1	Psoriatic Arthritis 01/2015
1	Neutropenia 10/2014
1	beta-Thalassemia (Cooley's Anemia) 04/2014
1	Iron Overload 04/2014
1	Hyperplasia 04/2014

Drug/Important Bio-Agent (IBA)

11	Lenalidomide (CC 5013)FDA Link 11/2017 - 10/2010
4	pomalidomideIBA 11/2016 - 01/2014
3	Phosphotransferases (Kinase)IBA 01/2020 - 10/2013
3	LigandsIBA 08/2015 - 04/2014
3	Alemtuzumab (Campath)FDA Link 02/2006 - 02/2002
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2011
2	3- (5- amino- 2- methyl- 4- oxoquinazolin- 3(4H)- yl)piperidine- 2,6- dioneIBA 01/2019 - 08/2015
2	Transcription Factors (Transcription Factor)IBA 10/2018 - 08/2011
2	Biomarkers (Surrogate Marker)IBA 12/2016 - 01/2015
2	Immunomodulating AgentsIBA 11/2016 - 01/2014
2	AlbuminsIBA 10/2015 - 10/2014
2	130-nm albumin-bound paclitaxelIBA 10/2015 - 10/2014
2	Mechanistic Target of Rapamycin Complex 1IBA 10/2015 - 10/2013
2	Mechanistic Target of Rapamycin Complex 2IBA 10/2015 - 10/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2015 - 10/2014
2	TOR Serine-Threonine KinasesIBA 10/2015 - 04/2015
2	ActRIIA-mIgG2aFc fusion proteinIBA 08/2015 - 04/2014
2	Erythropoietin FDA Link 08/2015 - 04/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2015 - 04/2012
2	fludarabineIBA 02/2006 - 02/2002
2	Melphalan (Alkeran)FDA LinkGeneric 02/2006 - 02/2002
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2004 - 02/2002
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022
1	AntigensIBA 01/2021
1	quizartinibIBA 01/2020
1	iberdomideIBA 10/2018
1	Thalidomide (Thalomid)FDA Link 05/2016
1	Bortezomib (Velcade)FDA Link 03/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2016
1	cremophor ELIBA 10/2015
1	CC-223IBA 10/2015
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 10/2015
1	MTOR InhibitorsIBA 10/2015
1	ACE-011IBA 08/2015
1	activin receptor type II-A (activin A receptor, type II)IBA 08/2015
1	Hemoglobins (Hemoglobin)IBA 08/2015
1	Rituximab (Mabthera)FDA Link 07/2015
1	Monoclonal AntibodiesIBA 07/2015
1	Vincristine (Oncovin)FDA LinkGeneric 04/2015
1	mafosfamideIBA 04/2015
1	Antineoplastic Agents (Antineoplastics)IBA 04/2015
1	Drug CombinationsIBA 04/2015
1	Prednisolone (Predate)FDA LinkGeneric 04/2015
1	apremilastIBA 01/2015
1	Phosphodiesterase 4 InhibitorsIBA 01/2015
1	CreatinineIBA 10/2014
1	SolventsIBA 10/2014
1	BilirubinIBA 10/2014
1	Activin Receptors (Activin Receptor)IBA 04/2014
1	luspaterceptIBA 04/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2014
1	GlobinsIBA 04/2014
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 04/2014
1	CytokinesIBA 04/2014
1	Ligases (Synthetase)IBA 01/2014
1	Cullin Proteins (Cullins)IBA 01/2014
1	DNA (Deoxyribonucleic Acid)IBA 10/2013
1	6- (4- (1H- 1,2,4- triazol- 3- yl)phenyl)- 1- (2- (tetrahydro- 2H- pyran- 4- yl)ethyl)- 1H- imidazo(4,5- b)pyrazin- 2(3H)- oneIBA 10/2013
1	CC214-2IBA 10/2013
1	epidermal growth factor receptor VIIIIBA 10/2013
1	Sirolimus (Rapamycin)FDA Link 10/2013
1	Adenosine Triphosphate (ATP)IBA 10/2013
1	Cetuximab (Erbitux)FDA Link 01/2013

Therapy/Procedure

7	Therapeutics 04/2016 - 02/2002
4	Homologous Transplantation 02/2006 - 12/2004
4	Transplantation 02/2006 - 10/2002
3	Stem Cell Transplantation 06/2005 - 10/2002
2	Autologous Transplantation 06/2005 - 10/2002
1	Immunomodulation 10/2018
1	Injections 10/2015
1	Drug Therapy (Chemotherapy) 04/2015